Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Curr Opin Virol. 2012 Jul 6;2(4):508–514. doi: 10.1016/j.coviro.2012.06.004

Table 2.

Detection of SV40 DNA by PCR in Lymphomasa

Author, year Country SV40 DNA by PCR [no. positive/no. tested (%)]
Lymphoma Control
Amara et al., 2007 Tunisia 63/108 (56) 4/60 (6)b
Zekri et al., 2007 Egypt 85/158 (54) 4/34 (12)b
Shivapurkar et al., 2002 US 29/68 (43) 5/120 (4.2)
Vilchez et al., 2002 US 64/154 (42) 0/240 (0)
Shivapurkar et al., 2004 US 33/90 (36) 1/56 (1.2)
Meneses et al., 2005 Costa Rica 30/125 (24) 0/91 (0)
Vilchez et al., 2005 US 12/55 (22) 0/19 (0)
David et al., 2001 US 15/79 (19) 19/187 (10)b
Martini et al., 1998 Italy 11/79 (14) 3/50 (6)b
Chen et al., 2006 Taiwan 13/91 (14) 0/106 (0)
Nakatsuka et al., 2003 Japan 14/122 (11) 3/64 (4.7)b
Capello et al., 2003 Spain, Italy 17/500 (3) 0/15 (0)
Daibata et al., 2003 Japan 3/125 (2) 0/31 (0)
MacKenzie et al., 2003 UK 0/152 (0) 0/45 (0)
Sui et al., 2005 Tasmania 0/50 (0) 0/50 (0)
Schüler et al., 2006 Germany 0/77 (0) 0/61 (0)
TOTAL 389/2033 (19.1)c 39/1207 (3.2)b,c
a

See Butel [34] for original references.

b

Among control samples positive for SV40 were 28 blood samples from noncancer patients or healthy individuals.

c

p<0.001 (Z test of proportions).